Robert Besthof
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Besthof
Robert Besthof was last confirmed as CEO at NRX Pharmaceuticals, Inc. (NRXP) in a filing dated June 21, 2022. NRX Pharmaceuticals, Inc. reported in an 8-K filed February 23, 2023 that Robert Besthof resigned as Head of Operations and Chief Commercial Officer, effective February 16, 2023. Robert Besthof has spoken on 3 earnings calls across 1 company, most recently for NRX Pharmaceuticals, Inc. on June 30, 2022.
“On February 16, 2023, Mr. Robert Besthof, NRx Pharmaceuticals, Inc.'s (the "Company") Head of Operations and Chief Commercial Officer, notified the Company of his resignation.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
NRX Pharmaceuticals, Inc. (NRXP)
SEC 8-K
2021-05-24–2023-02-16
-
Start not stated–2022-06-21
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.